Ophthalmologists have documented what is believed to be the first reported case of permanent loss of visual acuity that may have been induced by SARS-CoV-2, the virus that causes COVID-19. Read more
Roche’s faricimab meets primary endpoint in DME trial
Swiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME) after it produced a similar effect to Eylea in twin clinical trials, but with half the dosing regimen in several patients. Read more
Clinical trial results reinforce potential new treatment for DME
Novartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to treat diabetic macular edema (DME). Read more
Contact lens that enhances tear flow could prevent dry eye
A grant from CooperVision has supported a team of researchers from the Terasaki Institute for Biomedical Innovation in Los Angeles to develop a contact lens prototype that uses tears to monitor patient health. Read more
Researchers argue sore eyes should replace conjunctivitis as COVID-19 symptom
Sore eyes are the most significant vision-based indicator of COVID-19, according to new research published in the journal BMJ Open Ophthalmology, which calls for a change in the way symptoms are classified. Read more
Screening vital to eliminating COVID transmission risk through donor cornea
Researchers have analysed the prevalence of COVID-19 in human post-mortem ocular tissues, highlighting the importance of the donor screening process. Read more
Charity donates $160K for inherited retinal disease research
Retina Australia has awarded a total of $160,000 in study grants to some of the biggest names in Australian retinal research. Read more
Ophthalmologists treat rare corneal bee sting
Ophthalmologists have detailed how they treated an unlikely case of a corneal bee sting in a renowned peer-reviewed medical journal this month. Read more
Myopia Profile and CORE join forces
The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed a new alliance with the renowned Centre for Ocular Research & Education (CORE). Read more
Study shows gene therapy potential to regenerate optic nerve, Aussie professor says
A Melbourne professor has helped lead new research using a gene therapy to regenerate damaged optic nerve fibres, in a discovery that could determine future glaucoma treatments. Read more